Early detection of fetal chromosomal characteristics using non-invasive methods

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate a novel non-invasive prenatal diagnostic method that utilizes extravillous trophoblast cells obtained from the cervix of pregnant women as early as the 7th week of pregnancy. By analyzing these cells, the researchers seek to identify fetal chromosomal abnormalities and genetic diseases much earlier than current methods allow, which typically start at the 11th week of amenorrhea. The study will involve multiple visits throughout the pregnancy to assess the effectiveness and accuracy of this approach. The goal is to provide timely and accurate genetic information to expectant mothers, particularly those at high risk for genetic disorders.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pregnant woman
* Singleton pregnancy
* Pregnancy between 7 and 16 weeks of amenorrhea (WA)
* Woman ≥ 18 years
* Woman who has signed an informed consent
* Woman affiliated to social security or equivalent scheme

Exclusions Criteria:

* Person under guardianship or curatorship
* Person placed under legal protection
* Person unable to provide the participant with informed consent.

Where it's running

• CHU de Montpellier
  Montpellier, France, France Recruiting

Study contacts

• Principal investigator: Vincent GATINOIS, MD — University Hospital, Montpellier
• Study coordinator: Vincent GATINOIS, MD
• Email: v-gatinois@chu-montpellier.fr
• Phone: 0 67 33 68 66

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prenatal yoga to help with birth experience and body image

  This study tests whether a prenatal yoga program can improve how pregnant women perceive traumatic birth, how they feel about their bodies, and their preferred delivery method.

  Recruiting Saglik Bilimleri Universitesi · Bartın, Bartın · NCT07585916

• Preventing abdominal stretch marks in expectant mothers with Stratamark

  This program will try Stratamark on pregnant women to see if applying it to the abdomen prevents stretch marks during pregnancy and after birth.

  Recruiting Stratpharma AG · Brisbane · NCT07467837

• Oral health knowledge in pregnant women: does a one-time information leaflet help?

  A one-time printed leaflet is tested to see if it improves oral health knowledge in pregnant women attending Hospital La Fe.

  Recruiting University of Valencia · Valencia, Valencia · NCT07413393

• Outpatient induction of labour with a double‑balloon transcervical catheter for low‑risk pregnant women

  This trial will test whether starting cervical ripening at home with a double‑balloon catheter is as safe, acceptable, and time‑efficient as staying in hospital for low‑risk pregnant women due for induction of labour.

  Recruiting at 2 sites Nantes University Hospital · Nantes, Loire Atlantique and 1 other locations · NCT07265518

• Using placental blood markers to detect fetal stress during labor

  This study will test whether levels of placental markers (sFlt-1, PlGF, and their ratio) can help predict which pregnant people (≥32 weeks) may experience fetal distress during labor.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna and 1 other locations · NCT07258329

• How ultrafine particles and micro‑nano plastics affect fetal development

  This project will test whether pregnant women’s exposure to ultrafine particulate matter and micro‑nano plastics increases the chance of preterm birth and later non‑communicable diseases in their children.

  Recruiting Instituto de Investigacion Sanitaria La Fe · Valencia, Valencia · NCT07238608

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.